 |
 |
 |
|
|
 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
 |
|
 |
|
||||||||||||
| The company expects that its new plant in Orel region will provide 30% of Russia’s needs in insulin. Hereupon, the designed capacity of the plant will permit to export substantial portion of the product to the countries of Europe and former USSR. In future “Bioton” management plans to build in Orel region two more pharmaceutical plants for manufacturing immuno-stimulators. |
|||||||||||||||||
 |
 |
 |
|||||||||||||||
|
|
|
|
||||||||||||||||
|
|
|
